Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel euglycemic and hypolipidemic agents. 1

B B Lohray1, V Bhushan, B P Rao

  • 1Medicinal and Organic Chemistry, Pharmacology, and Clinical Research, Dr. Reddy's Research Foundation, Bollaram Road, Miyapur Hyderabad 500 050, India.

Journal of Medicinal Chemistry
|May 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and structure of 9-methyl-1,10-di-hydro-pyrazolo-[3,4-<i>a</i>]carbazole.

Acta crystallographica. Section E, Crystallographic communications·2026
Same author

Influence of Nd<sup>3+</sup> ion on piezoelectric studies in lead barium niobate ferroelectric ceramics for device applications.

Heliyon·2024
Same author

'Is it time to standardise elective nephrostomies as day case procedures?'- a single-centre retrospective study.

Clinical radiology·2024
Same author

Effect on growth performance, carcass traits, and myostatin gene expression in Aseel chicken fed varied levels of dietary protein in isocaloric energy diets.

Tropical animal health and production·2023
Same author

Critical Appraisal of Paediatric Embryonal Cancers Treated with Image-guided Intensity-modulated Proton Therapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Advancements in MXene-Polymer Nanocomposites in Energy Storage and Biomedical Applications.

Polymers·2022

New thiazolidinedione compounds show promising antihyperglycemic and hypolipidemic effects. The indole analogue DRF-2189 demonstrates potent insulin sensitization, making it a candidate for further diabetes research.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Endocrinology

Background:

  • Thiazolidinediones are a class of compounds with known antihyperglycemic properties.
  • Existing treatments like troglitazone have limitations, necessitating the development of novel agents.
  • Insulin resistance is a key factor in type 2 diabetes mellitus.

Purpose of the Study:

  • To synthesize and evaluate novel (heterocyclyl)ethoxy]benzyl]-2,4-thiazolidinedione derivatives.
  • To assess the antihyperglycemic, euglycemic, and hypolipidemic activities of these compounds.
  • To identify potent insulin sensitizers for potential therapeutic use in diabetes.

Main Methods:

  • Synthesis of unsaturated and saturated 2,4-thiazolidinedione derivatives via condensation and hydrogenation.

Related Experiment Videos

  • In vivo evaluation of antihyperglycemic and hypolipidemic activity in animal models.
  • Pharmacokinetic and tissue distribution studies of lead compounds.

    • Main Results:

    • Synthesized compounds exhibited significant antihyperglycemic activity.
    • Several derivatives demonstrated superior euglycemic and hypolipidemic effects compared to troglitazone.
    • The indole analogue DRF-2189 showed potent insulin sensitization, comparable to BRL-49653 in obese mouse models.
    • DRF-2189 exhibited favorable pharmacokinetic properties and tissue distribution.

    Conclusions:

    • The synthesized thiazolidinedione derivatives represent a promising class of compounds for managing hyperglycemia and dyslipidemia.
    • DRF-2189 is a highly effective insulin sensitizer with potential for further development as an anti-diabetic drug.
    • The favorable profile of DRF-2189 warrants its selection for advanced preclinical evaluation.